These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
109 related items for PubMed ID: 11400143
1. Expression of the tumour necrosis factor receptor-associated factors 1 and 2 in Hodgkin's disease. Murray PG, Flavell JR, Baumforth KR, Toomey SM, Lowe D, Crocker J, Ambinder RF, Young LS. J Pathol; 2001 Jun; 194(2):158-64. PubMed ID: 11400143 [Abstract] [Full Text] [Related]
2. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells. Izban KF, Ergin M, Martinez RL, Alkan S. Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929 [Abstract] [Full Text] [Related]
3. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas. Murray PG, Swinnen LJ, Flavell JR, Ragni MV, Baumforth KR, Toomey SM, Filipovich AH, Lowe D, Schnell CS, Johl J, Gulley M, Young LS, Ambinder RF. Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226 [Abstract] [Full Text] [Related]
4. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease. Knecht H, Berger C, McQuain C, Rothenberger S, Bachmann E, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF. Oncogene; 1999 Nov 25; 18(50):7161-7. PubMed ID: 10597317 [Abstract] [Full Text] [Related]
5. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. Herbst H, Samol J, Foss HD, Raff T, Niedobitek G. J Pathol; 1997 Jul 25; 182(3):299-306. PubMed ID: 9349232 [Abstract] [Full Text] [Related]
6. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Br J Cancer; 2001 May 04; 84(9):1227-34. PubMed ID: 11336475 [Abstract] [Full Text] [Related]
8. Phenotypic modulation of Hodgkin and Reed-Sternberg cells by Epstein-Barr virus. Herbst H, Raff T, Stein H. J Pathol; 1996 May 04; 179(1):54-9. PubMed ID: 8691346 [Abstract] [Full Text] [Related]
9. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?]. Beck Z, Illés A, Keresztes K, Bessenyei B, Szöllosi Z, Kis A, Oláh E. Orv Hetil; 2006 Aug 20; 147(33):1539-44. PubMed ID: 17037676 [Abstract] [Full Text] [Related]
13. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease. Beck A, Päzolt D, Grabenbauer GG, Nicholls JM, Herbst H, Young LS, Niedobitek G. J Pathol; 2001 Jun 20; 194(2):145-51. PubMed ID: 11400141 [Abstract] [Full Text] [Related]
14. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma. Gulley ML, Glaser SL, Craig FE, Borowitz M, Mann RB, Shema SJ, Ambinder RF. Am J Clin Pathol; 2002 Feb 20; 117(2):259-67. PubMed ID: 11863222 [Abstract] [Full Text] [Related]
15. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease. Meij P, Vervoort MB, Bloemena E, Schouten TE, Schwartz C, Grufferman S, Ambinder RF, Middeldorp JM. J Med Virol; 2002 Nov 20; 68(3):370-7. PubMed ID: 12226824 [Abstract] [Full Text] [Related]
16. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease. Takahashi H, Fujita S, Shibata Y, Tsuda N, Okabe H. Anal Cell Pathol; 1996 Nov 20; 12(2):71-83. PubMed ID: 8986292 [Abstract] [Full Text] [Related]
17. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S. Mod Pathol; 2003 Jun 20; 16(6):566-73. PubMed ID: 12808062 [Abstract] [Full Text] [Related]
18. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, Viviani S, Bonfante V, Giardini R, Chilosi M, Kittas C, Gianni AM, Bonadonna G, Pizzolo G, Pangalis GA, Cabanillas F, Sarris AH. Clin Cancer Res; 2003 Jun 20; 9(6):2114-20. PubMed ID: 12796376 [Abstract] [Full Text] [Related]
19. Major histocompatibility complex (MHC)-I and MHC-II expression in Hodgkin's disease in relation to the presence of Epstein-Barr Virus (EBV). Tzardi M, Kouvidou C, Papakonstantinou E, Datseris G, Darivianaki K, Karidi E, Eliopoulos G, Delidis G, Rontogianni D, Kanavaros P. Anticancer Res; 1996 Jun 20; 16(2):827-31. PubMed ID: 8687136 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection. Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Cancer Epidemiol Biomarkers Prev; 1998 Dec 20; 7(12):1117-21. PubMed ID: 9865430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]